about
Migraine among medical students in Kuwait UniversityStatus migrainosus as an initial presentation of multiple sclerosis.Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?Early versus Late Surgical Treatment for Neurogenic Thoracic Outlet Syndrome.Prevalence of Primary Headache Disorders in Kuwait.The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study.Risk Factors, Subtypes, and Outcome of Ischemic Stroke in Kuwait: A National Study.Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait.Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis.Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994-2013.Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in Kuwait.Burden of migraine in a Kuwaiti population: a door-to-door survey.Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence.Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.Alternative diagnoses in patients referred to specialized centers for suspected MS.A longitudinal study of JC virus serostatus stability among multiple sclerosis patients.Real-world use of fingolimod in patients with relapsing remitting multiple sclerosis: a retrospective study using the national multiple sclerosis registry in Kuwait.Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.Demographics and clinical characteristics of multiple sclerosis in Kuwait
P50
Q33645453-4B094F06-DF50-4D95-8701-B937D02885FFQ35020165-5E5552BA-8977-4883-9DE3-A5EC46D7D2D3Q36179420-6F5DCAAD-5D8B-47DC-8A97-8A562F132DF0Q37200089-DBBEC13B-C600-456B-AEEB-A3876C5D5492Q38669775-A4077DD1-7793-49F5-9072-AA5FB4729617Q38847493-C3A15BE8-CA5F-4B5B-9164-82BC0F7F37BCQ39671074-9F13895F-38A4-43F3-AC79-685ADD8F924CQ39993375-A3F7CADD-B543-436E-9E60-0B853A1F831EQ40297591-02553696-95FA-4A0B-BBE8-007D65626BFAQ40446539-B55DFCC8-A055-4422-BE02-4DAEA57C844AQ40848013-A17B01C8-D961-4791-BD0D-B9A6EFE7A41FQ40983462-90EC3522-96BE-42B6-96CD-91530A985402Q42288520-848C6CF2-FDC7-4F80-A1AA-2CF0DB7192FAQ42701383-43BA1755-6E0B-4578-9FF0-1A97AF26FB95Q44014309-DC9D15CA-0E15-4C33-B3C6-11E8CE685CBCQ46263604-35DCCC35-0789-4C15-8542-61EB51DFA108Q46650963-24912633-9170-4D55-8FFD-E59310DF1CC1Q46681605-21B70548-300B-4BE3-9AA9-186492A2DA28Q47216497-3A79EF81-3299-4E36-91ED-311876CD9B18Q50135742-F8AACDD9-924E-4DBC-9B36-2DC809BF3A0FQ51128752-A3FF952A-3568-49E7-96F1-B72B68074AB3Q53824227-325F0FBD-65F0-4F8D-A0A9-6064AAAAF2CFQ85321889-E87A3BE8-77F5-4A76-8DEE-3506AA594894
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Samar Farouk Ahmed
@ast
Samar Farouk Ahmed
@en
Samar Farouk Ahmed
@es
Samar Farouk Ahmed
@nl
type
label
Samar Farouk Ahmed
@ast
Samar Farouk Ahmed
@en
Samar Farouk Ahmed
@es
Samar Farouk Ahmed
@nl
prefLabel
Samar Farouk Ahmed
@ast
Samar Farouk Ahmed
@en
Samar Farouk Ahmed
@es
Samar Farouk Ahmed
@nl
P106
P1153
55768448200
P31
P496
0000-0002-9026-9219